Stock BHVN BIOHAVEN LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Biohaven Ltd.

Equities

BHVN

VGG1110E1079

Real-time Estimate Cboe BZX
Other stock markets
 11:58:46 2024-06-04 am EDT 		5-day change 1st Jan Change
34.2 USD -2.56% Intraday chart for Biohaven Ltd. -4.41% -17.99%
May. 29 Biohaven Ltd. Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas Including Immunology, Neuroscience, Metabolic Disorders and Oncology At Annual Investor R&D Day CI
May. 29 Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate BHV-1510 in Advanced or Metastatic Epithelial Tumors CI
2a8ff333b.SPUrE5xIgkIVnnztBa99ePQt4-JZWBN4Uf9c3Htc3KU.OK9mcKkq0Q447R25V-Y_T5ZM0bMxNCEbF68-shEOstMpwm94sWXJLkbRCw~acf1abe79d7057ea481df47e23b9f522
  1. Stock Market
  2. Equities
  3. BHVN Stock
  4. Charts Biohaven Ltd.
  5. News Chart